UnitedHealth Group is charging patients a markup for key life-saving drugs that could easily exceed their cost by a factor of ...

The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, ...

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 ...

The FTC study examines the practices of PBMs to ensure fair competition and transparency. The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty ...

CVS Health Corporation is a vertically integrated healthcare corporation in the United States. The company owns a leading ...

Agency commissioners voted unanimously on Tuesday to publish the report, which makes similar allegations against the ...

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

The nation's three largest pharmacy benefit managers have significantly marked up the prices of certain medicines, including ...

WASHINGTON >> The nation’s three largest pharmacy benefit managers have significantly marked up the prices of certain ...

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in ...

The Federal Trade Commission on Tuesday released an interim report saying that powerful drug middlemen marked up drugs for ...